Publications Explore the research backing our approach See company presentations, and learn more about the progress we’re making in pioneering next-generation therapies for a range of autoimmune diseases. Search Publications December 18, 2024 BMJ Neurology Open: Antigen-specific immune therapy (CNP-106) for treatment of generalised myasthenia gravis: rationale and design of first-in-human randomised controlled trial August 1, 2022 The Journal of Immunology: Tolerogenic immune-modifying nanoparticles encapsulating multiple recombinant pancreatic β cell proteins prevent onset and progression of type 1 diabetes in nonobese diabetic mice February 6, 2022 Frontiers: Masked delivery of allergen in nanoparticles safely attenuates anaphylactic response in murine models of peanut allergy July 1, 2021 Gastroenterology: TAK-101 nanoparticles induce gluten-specific tolerance in celiac disease: a randomized, double-blind, placebo-controlled July 21, 2020 Frontiers: Specificity of the T cell response to protein biopharmaceuticals
